Custom peptide synthesis is the commercial production of peptides for use in biochemistry, biology, biotechnology, pharmacology and molecular medicine. Custom peptide synthesis provides synthetic peptides as valuable tools to biomedical laboratories.
Customized Peptide Synthesis Market contains market size and forecasts of Customized Peptide Synthesis in Global, including the following market information:
- Global Customized Peptide Synthesis Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Customized Peptide Synthesis market was valued at 243.5 million in 2021 and is projected to reach US$ 308.7 million by 2028, at a CAGR of 3.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Under 75% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Customized Peptide Synthesis include Bachem, PolyPeptide, GL Biochem, Xinbang, Hybio, USVPeptides, Thermofischer, ScinoPharm and Genscript, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Customized Peptide Synthesis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Customized Peptide Synthesis Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Customized Peptide Synthesis Market Segment Percentages, by Type, 2021 (%)
- Under 75%
- 75% to 95%
- Above 95%
Global Customized Peptide Synthesis Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Customized Peptide Synthesis Market Segment Percentages, by Application, 2021 (%)
- Commercial
- Academic Research
Global Customized Peptide Synthesis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Customized Peptide Synthesis Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Customized Peptide Synthesis revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Customized Peptide Synthesis revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bachem
- PolyPeptide
- GL Biochem
- Xinbang
- Hybio
- USVPeptides
- Thermofischer
- ScinoPharm
- Genscript
- AnaSpec
- New England Peptide
- CPC Scientific
- JPT
- 21st Century Bio
- LifeTein
- Proimmune
- Biomatik